Cost-utility analysis of topical intranasal steroids for otitis media with effusion based on evidence from the GNOME trial

Value in Health

Volumn 13, Issue 5, 2010, Pages 543-551

  Petrou, Stavros ^a   Dakin, Helen ^a   Abangma, Giselle ^a   Benge, Sarah ^b   Williamson, Ian ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

cost effectiveness; cost utility analysis; otitis media with effusion; randomized controlled trial

Indexed keywords

MOMETASONE FUROATE; PLACEBO;

AGED; ANALYTIC METHOD; ARTICLE; BOOTSTRAPPING; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DOUBLE BLIND PROCEDURE; ECONOMIC EVALUATION; FEMALE; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH SERVICE; OTITIS MEDIA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT DURATION; TYMPANOMETRY;

EID: 77955373037     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2010.00711.x     Document Type: Article

References (39)

1. Stool SE, Berg AO, Berman S, et al. Otitis Media with Effusion in Children. Guideline Technical Report. No 12. AHCPR. Pub No.95-0621. Rockville, MD : US Department of Health and Human Services, 1994.
2. Zielhuis GA, Rach GH, Broek PV. Screening for otitis media with effusion in preschool children. Lancet 1989 1 : 311 314.
3. Casselbrant ML, Brostoff LM, Cantekin EI, et al. Otitis media with effusion in preschool children. Laryngoscope 1985 95 : 428 436.
4. Haggard M, Hughes E. Screening Children's Hearing: A Review of the Literature and Implications of Otitis Media. London, UK : HMSO, 1991.
5. HES4.DOH. Hospital Episode Statistics. Grommets. (D15). London, UK : Department of Health, 2004. Available from: http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsStatistics/DH-066322 [Accessed December 16, 2009 CC, van der Voort JH. Oral Or Topical Nasal Steroids for Hearing Loss Associated with Otitis Media with Effusion in Children Cochrane Review) Cochrane Library, Issue 2. Oxford, UK : Update Software, 2002.
6. Lous J, Burton M, Felding J, et al. Grommets (Ventilation Tubes) for Hearing Loss Associated with Otitis Media with Effusion in Children. Cochrane Library, Issue 1. Chichester, UK : John Wiley & Co, 2005.
7. Griffin GH, Flynn C, Bailey RE, et al. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database Syst Rev 2006 4 Art. No.: CD003423. doi:10.1002/14651858. CD003423.pub2.
8. Cantekin EI, McGuire TW. Antibiotics are not effective for otitis media with effusion: reanalysis of meta-analysis. Otorhinolarynol Nova 1998 8 : 214 222.
9. Williamson I, Benge S, Mullee M, et al. Consultations for middle ear disease, antibiotic prescribing and risk factors for re-attendance: a case linked cohort study. BJGP 2006 56 : 170 175.
10. Tracy JM, Demain JG, Hoffman KM, et al. Intranasal beclomethasone as an adjunct to treatment of chronic middle ear effusion. Ann Allerg Asthma Im 1998 80 : 198 206.
11. Fokkens WJ, Scadding GK. Perennial rhinitis in the under 4 s: a difficult problem to treat safely and effectively? A comparison of intranasal fluticasone proprionate and ketotifen in the treatment of 2-4 year old children with perennial rhinitis. Pediatr Allergy Immunol 2004 15 : 261 266.
12. Cengel S, Akyol MU. The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. Int J Ped Otorhinolaryngol 2006 70 : 639 645.
13. Yaman H, Ozturk K, Uyar Y, et al. Effectiveness of corticosteroids in otitis media with effusion: an experimental study. JLO 2008 122 : 25 30.
14. Rosenfeld RM, Mandel EM, Bluestone CD. Systemic steroids for otitis media with effusion in children. Arch Otolaryngol Head Neck Surg 1991 117 : 984 989.
15. Williamson I, Benge S, Barton S, et al. A double-blind randomised placebo controlled trial of topical intra-nasal corticosteroids in 4-11 year old children with persistent bilateral Otitis Media with Effusion in primary care. BMJ 2009 Dec. 16 doi: 10.1136/bmj.b4984 [Epub ahead of print I, Benge S, Barton S, et al. A double-blind randomised placebo controlled trial of topical intra-nasal corticosteroids in 4-11 year old children with persistent bilateral Otitis Media with Effusion in primary care. Health Technol Assess 2009 13 : 1 274.
16. Timmerman AA, Meesters CM, Anteunis LJ, et al. Psychometric evaluation of the OM8-30 questionnaire in Dutch children with otitis media. Eur Arch Otorhinolaryngol 2008 265 : 1047 1056.
17. National Institute for Health and Clinical Excellence (NICE). Guide to the Methods of Technology Appraisal. London, UK : NICE 2007.
18. Department of Health. NHS Reference Costs 2006. London, UK : Department Health 2006.
19. Netten A, Curtis L. Unit Costs of Health and Social Care. Canterbury, UK : Personal Social Service Research Unit, University of Kent, 2007.
20. National Statistics. Prescription cost analysis: England. Available from: http://www.ic.nhs.uk/statistics-and-data-collections/primary-care/ prescriptions/prescription-cost-analysis-2006 [Accessed June 15, 2009 GW, Furlong W, Feeny D, et al. Multi-attribute preference functions: Health Utilities Index. Pharmacoeconomics 1995 7 : 503 520.
21. Brooks R. EQ-5D, the current state of play. Health Policy 1996 37 : 53 72.
22. Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care 2002 40 : 113 128.
23. Furlong W, Feeny D, Torrance GW, et al. Multiplicative multi-attribute utility function for the Health Utilities Index mark 3 (HUI3) system: a technical report. Centre for Health Economics and Policy Analysis, McMaster University, Canada. Working Paper 98-11, December 1998.
24. Furlong WJ, Feeny DH, Torrance GW, et al. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001 33 : 375 384.
25. Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005 14 : 487 496.
26. Briggs A, Clark T, Wolstenholme J, et al. Missing. presumed at random: cost-analysis of incomplete data. Health Econ 2003 12 : 377 392.
27. Yu LM, Burton A, Rivero-Arias O. Evaluation of software for multiple imputation of semi-continuous data. Stat Methods Med Res 2007 16 : 243 258.
28. Dakin H, Petrou S, Haggard M, et al. Mapping analyses to estimate health utilities based on responses to the OM8-30 otitis media questionnaire. Qual Life Res 2010 19 : 65 80.
29. Royston P. Multiple imputation of missing values: update of ice. Stata J 2005 5 : 527 536. (Pubitemid 43708457)
30. Efron B, Tibshirani R. An Introduction to the Bootstrap. New York, USA : Chapman and Hall, 1993.
31. Brigg AH, Gray AM. Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess 1999 3 : 1 134.
32. Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998 S65 S80.
33. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999 18 : 341 364.
34. Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996 313 : 275 283.
35. van Balen FAM, de Melker RA, Touw-Otten FW. Double blind randomized trial of co-amoxiclav versus placebo for persistent otitis media with effusion in general practice. Lancet 1996 348 : 713 716.
36. Mendes Leal M, Marques P, Vaz R, et al. Factors in severity of OME seen in secondary care. ESPO, 8th International Conference Proceedings. June 11, 2008. Abstract 5SOP4.
37. Petrou S. Methodological issues raised by preference-based approaches to measuring the health status of children. Health Econ 2003 12 : 697 702.
38. Sung L, Petrou S, Ungar W. Measuring health utilities in children and their parents. In : Ungar W, ed. Economic Evaluation in Child Health. Oxford, UK : Oxford University Press, 2009.
39. Eiser C, Morse R. Quality-of-life measures in chronic diseases of childhood. Health Technol Assess 2001 5 : 1 156.